Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Applied Therapeutics

NASDAQ APLT
$4.82 0.0000 0.0000%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 12 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

406.06M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
356.59M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.05
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
84.24M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
43.88 %

Upcoming events Applied Therapeutics

All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart Applied Therapeutics

Stock analysis Applied Therapeutics

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-3.41 27.69
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
-23.68 3.65
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-5.56 9.48
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.77 -0.16
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
694.28 7.67

Price change Applied Therapeutics per year

13.04$ 29.80$
Min Max

Summary analysis Applied Therapeutics

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Applied Therapeutics

Revenue and net income Applied Therapeutics

All parameters

Stock news Applied Therapeutics

All news
5 January в 02:50

Stocks to Watch: Dermata Therapeutics, Applied Therapeutics, Fusion Pharmaceuticals

5 January в 02:50

Stocks to Watch: Dermata Therapeutics, Applied Therapeutics, Fusion Pharmaceuticals

5 January в 02:25

Applied Therapeutics Shares Sink 30% on AT-001 Trial Results

5 January в 02:20

Applied Therapeutics Shares Sink 30% on AT-001 Trial Results

3 January в 18:55

Applied Therapeutics Shares Hit 52-Week High on Govorestat Filings

3 January в 18:55

Applied Therapeutics Shares Hit 52-Week High on Govorestat Filings

6 September 2023 в 17:45

Applied Therapeutics Shares Rise 11% After Pre-NDA Meeting With FDA

6 September 2023 в 17:45

Applied Therapeutics Shares Rise 11% After Pre-NDA Meeting With FDA

24 April 2023 в 17:16

Applied Therapeutics Shares Rise 21% After Positive Data for Govorestat

24 April 2023 в 17:11

Applied Therapeutics Shares Rise 21% After Positive Data for Govorestat

4 January 2023 в 14:35

Applied Therapeutics in Partnership With Advanz Pharma for AT-007

4 January 2023 в 14:35

Applied Therapeutics in Partnership With Advanz Pharma for AT-007

6 October 2022 в 20:56

Applied Therapeutics Down 33% on Clinical Trial Update

6 October 2022 в 20:56

Applied Therapeutics Down 33% on Clinical Trial Update

23 June 2022 в 13:26

Applied Therapeutics Shares Slide Premarket After Stock Offering >APLT

23 June 2022 в 13:20

Applied Therapeutics Shares Slide Premarket After Stock Offering >APLT

22 June 2022 в 23:35

Applied Therapeutics Shares Dive 33% on Public Offering

22 June 2022 в 23:35

Applied Therapeutics Shares Dive 33% on Public Offering

3 June 2022 в 14:31

Applied Therapeutics Up After EMA Orphan Medicinal Product Designation

3 June 2022 в 14:31

Applied Therapeutics Up After EMA Orphan Medicinal Product Designation

About company Applied Therapeutics

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase I/II for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Address:
545 Fifth Avenue, New York, NY, United States, 10017
Company name: Applied Therapeutics
Issuer ticker: APLT
ISIN: US03828A1016
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2019-05-14
Sector: Healthcare
Industry: Biotechnology
Site: https://www.appliedtherapeutics.com

On which stock exchange are Applied Therapeutics (APLT) stocks traded?

Applied Therapeutics (APLT) stocks are traded on NASDAQ.

What is the ticker of Applied Therapeutics stocks (APLT)?

The stock ticker of Applied Therapeutics’s stocks or in other words, the code is APLT. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Applied Therapeutics (APLT) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Applied Therapeutics (APLT) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Applied Therapeutics (APLT) stocks traded?

Applied Therapeutics (APLT) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Applied Therapeutics (APLT) stocks today?

The current price of Applied Therapeutics stocks on 08.05.2024 is 4.82 dollars. per share.

What is the dynamics of Applied Therapeutics (APLT) stocks from the beginning of the year?

Applied Therapeutics (APLT) quotes have increased by 32.42% from the beginning of the year up to 4.82 dollars. per 1 stocks.

How much did Applied Therapeutics (APLT) stocks increase in мае 2024?

This month Applied Therapeutics (APLT) quotes have increased by 8.56% to 4.82 dollars. per share.

How much are Applied Therapeutics (APLT) stocks worth?

Today, on October, 08.05.2024 Applied Therapeutics’s (APLT) stocks cost 4.82 dollars..

What is the market capitalization of Applied Therapeutics (APLT)?

Capitalization is the market value of Applied Therapeutics (APLT) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 08.05.2024, the market capitalization of Applied Therapeutics (APLT) is estimated at about 406058461 dollars.